share_log

RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15

Benzinga ·  Oct 4 23:54  · Ratings

RBC Capital analyst Gregory Renza maintains Pacira BioSciences (NASDAQ:PCRX) with a Sector Perform and raises the price target from $14 to $15.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment